Cerba Research at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

Cerba Research brings 2 presentations to ESGCT 2026 in Hamburg. Its contribution covers laboratory analysis supporting cell and gene therapy trials. Work includes mapping vector integration sites with long-read sequencing and recovering intact DNA from lymphodepleted samples so CAR T vector analysis still works.

OrganizationESGCT 2026 Attendance
cerbaresearch.com
CDMOs & CROs
Specialty and central laboratory services for clinical trials, covering bioanalysis, genomics, histopathology and flow cytometry across a global lab network.
Poster
Wed Oct 28
1:30pm–3:30pm
Genome And Epigenome Landscapes With Crispr-Cas9 And Long-Read Sequencing Of Vector Integration Sites
Lentiviral vectors / Integrative vectors
Poster
Wed Oct 28
1:30pm–3:30pm
Scalable, reliable recovery of intact DNA from lymphodepleted samples for CAR-T vector analysis
Immunotherapy and CAR T cells

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Cerba Research

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction